III

phatbob198

The DOJ Director of Public Affairs confirmed news that a proposal to reschedule cannabis to schedule 3 has been moved to the OMB. >Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III," **Justice Department director of public affairs Xochitl Hinojosa said in a statement**. The DEA is a component of the Department of Justice. "Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” https://abcnews.go.com/US/wireStory/us-drug-control-agency-move-reclassify-marijuana-historic-109794268

phatbob198

Here is the full text, since it is behind a paywall: >Many U.S. cannabis businesses could become profitable for the first time if the Biden administration follows through on its plan to reclassify marijuana as a less dangerous drug. >That is because the change could lift a heavy income-tax burden: Section 280E of the federal tax code currently bars cannabis businesses from claiming deductions on many basic business expenses. That rule often results in an effective tax rate of 70% or more, wiping out most licensed marijuana retailers’ earnings. >“It’s an absolute game-changer,” said Boris Jordan, executive chairman of Curaleaf Holdings, which operates 145 dispensaries and 19 cultivation sites across the U.S. “It’s something we’ve been waiting for, for the better part of 10 years.” >The proposed rule could take months to complete and could be further stalled by lawsuits. The public, including state regulators and marijuana companies, would have a chance to comment and the White House would have to sign off on a final version of the rule before it could go into effect. >Marijuana is legal in some form in 40 states and the District of Columbia, but is illegal under federal law—and would remain so even if the Drug Enforcement Administration moved marijuana from Schedule I to the less-restrictive Schedule III, equivalent to prescription medications such as anabolic steroids and some combinations of acetaminophen and codeine. >Cannabis businesses would still have to contend with limited access to banking services and financing. They still wouldn’t be allowed to transport marijuana across state lines. And companies that sell marijuana in the U.S. still couldn’t be traded on U.S. stock exchanges. >A national survey conducted in 2022 by Whitney Economics, a cannabis industry research firm, found that fewer than 25% of cannabis businesses were profitable. Licensed U.S. cannabis companies this year are expected to make $31.4 billion in sales and pay $2.3 billion more in federal taxes than they would under normal business tax rules, according to Whitney Economics forecasts. >For companies that have been hanging on in hope of one day making it into the black, the policy change could be transformative. Business leaders said they could use the cash to invest more in marketing, offer better benefits to employees and expand into newly opened markets such as Ohio. Industry leaders said they are also optimistic that the policy shift could reduce the stigma around cannabis, bring more investors into the sector and make federal lawmakers more open to legalizing marijuana. >Congress created Section 280E of the tax code in 1982, when Sen. Bill Armstrong (R., Colo.) tucked the provision into a larger bill as the federal War on Drugs was ramping up. >The law denies many ordinary deductions and tax credits to businesses that are “trafficking in controlled substances” listed under Schedule I and II. >When marijuana was illegal at the federal and state levels, that deduction limit had a relatively small impact, and it mostly gave U.S. authorities an additional tool to go after drug dealers and impose taxes on top of criminal prosecutions. But state legalization combined with Section 280E created an odd hybrid. The cannabis industry looked like regular businesses in many respects—except for the income-tax bills. >“Draconian, I think, is putting it lightly,” said Charlie Bachtell, chief executive of Cresco Labs, which has dispensaries and production facilities across eight U.S. states. For each of the past two years, Cresco has paid between $70 million and $80 million more in U.S. federal taxes than it would have under normal business conditions, he said. Despite the hefty tax bill, Cresco in the last quarter of 2023 became free cash-flow positive for the first time since it went public in 2018. >The cannabis industry has “really been kind of stumbling its way forward because of the economic burdens of 280E,” said Brian Vicente, a cannabis lawyer in Denver. >The current tax rules allow cannabis businesses to deduct their cost of goods sold, so growers that put most of their resources into production don’t get hit hard. Businesses closer to the consumer get hammered by Section 280E. For instance, a retailer selling clothes or food can deduct rent, marketing and wages when calculating taxable income. But a cannabis retailer typically can’t take any of those deductions. >“It’s impossible to make those numbers work,” said Wanda James, CEO and co-founder of Simply Pure Brands, which has a dispensary in Colorado and a new branch about to open in New Jersey. “It’s just a question of how long is your runway.” >James, a former Navy officer, restaurateur and political organizer, was among the first Black cannabis licensees in Colorado. She said the tax change could lower the barriers to entry for women, people of color and veterans, many of whom have struggled to keep their cannabis businesses afloat after winning state lotteries for social-equity licenses. >The tax change could also shrink the gap in profitability between legal and illegal cannabis businesses, helping licensed businesses that have struggled to compete with the black market. Unlicensed operations can sell marijuana at lower prices and pay fewer administrative and regulatory costs. >More broadly, moving cannabis to Schedule III could create an unusual tax regime. Businesses would still face significant state taxes and high costs for banking and other services. But cannabis would actually have more favorable federal tax treatment than alcohol and tobacco, which are subject to federal excise taxes on top of income taxes. >Sens. Chuck Schumer (D., N.Y.), Cory Booker (D., N.J.) and Ron Wyden (D., Ore.) are reintroducing legislation that would decriminalize marijuana and impose federal excise taxes of up to 25%.

phatbob198

I think this section of an article I posted yesterday contains important info worth highlighting. >Notably, the DEA could reschedule cannabis by issuing a final order and bypass the notice and comment period, which would allow the change to become effective 30 days after publication in the Federal Register. **However, it seems certain that the DEA will elect to do so by proposed rule, which is followed by a comment period of between 30-90 days**. This comment period will be followed by a formal administrative hearing if requested, which rescheduling opponents will most certainly want, along with a flood of comments ranging from why cannabis should remain in Schedule I to why it should not be rescheduled lower than Schedule II. **While rescheduling to Schedule III is almost certain, it is critical that proponents submit comments as well**, in order to ensure a robust record supporting marijuana’s reclassification. We should start looking into how sumbitting comments during that period will work, and then make sure to disseminate that information.

RandomGenerator_1

The Cannabis Crossroads: How Schedule III and The Farm Bill Intersect " I have personally been involved in establishing the distribution of such beverages in mainstream venues such as sporting events, festivals, concert venues, c-stores, thousands of liquor stores, and the like. It is widely believed that these low dose Hemp D9 beverages are here to stay, and for good reason – beer, wine, and spirit sales have dipped across the country for several consecutive quarters. ... This concept is further bolstered by the fact that the federal government is on a path to reschedule marijuana from the most restrictive category (Schedule I) to a far less restrictive category – Schedule III. While this process will take some time (as a technical matter) and could get delayed or procedurally paused by a new President with different policies, attention will continue to focus on federally legal and already de-scheduled Hemp D9. ... Various government policy groups, many funded by MSO groups who seemingly refuse to do what their shareholders want – sell more products! – and who refuse to embrace the tenets of the mainstream CPG industry, continue to push against the present Farm Bill language and are actively seeking to undermine the current language. I have reached out to two MSO groups for comment on this issue, but have not gotten a reply by the time of this publication. It seems odd to me that certain larger MSO groups fail to see that Hemp D9 products are in fact a lifeline if and/or when they fail to comply with the rigorous standards that are generally applicable to a Schedule III compound producer/seller/marketer/manufacturer. To put it simply, it is not a given that any state-licensed marijuana sector business will qualify to become approved under the applicable medical supply chain standards, or that the federal government would even entertain such an approval – again, more on that in a subsequent article. If nothing else, the current hemp language is their backup plan, but many apparently fail to see this. ... This is not to say that all MSOs and large-scale marijuana sector interests feel this way. In fact, I currently serve (and have served) as a strategic advisor to many such MSOs and large-scale marijuana sector companies and they have embraced this strategy; and they see the writing on the wall; and they want to have a backup plan under any circumstance. But several of these imterests seek to redefine 'hemp' to exclude any sort of so-called ‘intoxicating’ compounds and/or drive all such compounds into the economically challenged, less-than-mainstream, overtaxed, intrastate, closed-loop dispensary system. ... Various market and consumer studies have shown that many cannabis consumers do not want to walk into dispensaries…but they will walk into a convenience store or a liquor store. https://www.forbes.com/sites/roberthoban/2024/05/03/the-cannabis-crossroads-how-schedule-iii-and-the-farm-bill-intersect/?sh=7a1cc55f2e8f Some Sunday reading. I know of at least one company who is playing into this strategy: Tilray.

noodlesinsauce

RE: The USA MJ Opportunity On one end, no restrictions at all means unlimited competition for flower, though barriers of entry for non-flower will be high enough for businesses to create moats. On the other end, high restrictions like we have now means limited access to consumers, distribution and capital. And no meaningful (legitimate) business to drive share price. The thesis for US MJ has always been the limited license opportunities where a market has 15-30 approved businesses, and not free-for-all markets like California, Oregon and Washington where the margins are deeply compressed, which in turn leads to zero notable US MJ businesses flourishing at scale in the West coast. As investors, we should be careful for what we wish for in the removal of restrictions. We need regulatory capture to continue to exist in meaningful ways to limit competition so the US MJ businesses we've invested in are valuable. RE: Schedule III I can't tell if S3 is the optimal balance for regulatory capture. But it's better than what we have now, and it's clear there's still no path to unlimited competition. I think our only issue is the excessively long timeframe for changes in the space. There is high probability, maybe even certainty, that a dollar invested in US MJ will grow. But the long timeframe means that alternative investments like even M7 or S&P500 will likely yield better than US MJ in the same period of time. It makes US MJ unattractive. Personally, things need to move significantly this year for me.

phatbob198

>Procedure for Rescheduling >The DEA has agreed with HHS’ recommendation for cannabis to be rescheduled to Schedule III, with Schedule III drugs defined as having a moderate to low potential for physical and psychological dependence (Schedule III drugs include ketamine, anabolic steroids, and testosterone). This rescheduling will have a significant impact on state-legal cannabis businesses, but some uncertainty remains. Once the DEA publishes its proposed rule, it will be reviewed by the White House Office of Management and Budget (“White House”) and if approved, it would then proceed to a public comment period. >Notably, the DEA could reschedule cannabis by issuing a final order and bypass the notice and comment period which would allow the change to become effective 30 days after publication in the Federal Register. However, it seems certain that the DEA will elect to do so by proposed rule, which is followed by a comment period of between 30-90 days. This comment period will be followed by a formal administrative hearing if requested, which rescheduling opponents will most certainly want, along with a flood of comments ranging from why cannabis should remain in Schedule I to why it should not be rescheduled lower than Schedule II. While rescheduling to Schedule III is almost certain, it is critical that proponents submit comments as well in order to ensure a robust record supporting marijuana’s reclassification. >Once the comment period and administrative hearing have concluded, the DEA will review the entire record and issue its final rule based on its analysis, HHS’ analysis, the comments submitted, and the administrative hearing record. The timeframe for issuing a final rule is uncertain and not statutorily defined, but since the DEA is required to review and respond to every comment submitted during the notice period, it could take some time. >Whether the DEA goes straight to issuing a final order or allows notice and comment, after the final decision/order is issued, it will not become effective until 30 days after it is published in the Federal Register. During this time, an aggrieved party that participated in the notice and comment period has 30 days to file a lawsuit to seek judicial review of the agency's decision. In the event of a lawsuit, it is possible the effective date of the reclassification is delayed by a court order. >Cannabis rescheduling is likely to inspire further federal regulations, but the nature of said regulations is uncertain. Since 2009, during the Obama administration, the federal government has declined to enforce federal law against the overwhelming majority of state compliant marijuana businesses. The federal government’s reluctance since the 2013 Cole Memorandum continued despite the DOJs enforcement guidance being rescinded during the Trump administration. It is possible we will see the DOJ reissue another enforcement memo. While it is still uncertain, enforcement action may follow cannabis rescheduling in an attempt to form a more cohesive national industry. >For example, rescheduling cannabis to Schedule III may push the FDA to enforce against false and misleading drug claims as it has for hemp products. The DEA would continue to regulate cannabis as it had under Schedule I, however, they could now require dispensaries to conform to pharmacy regulations and the significant requirements associated with such. It is unclear but unlikely that the DEA will enforce pharmacy requirements upon state-legal dispensaries, since the difficulties and required resources associated with such enforcement will likely be too burdensome for the DEA immediately following rescheduling. >The FDA may also become more involved in the regulation of cannabis, particularly concerning cannabis products’ dietary supplements and conventional food claims. While regulatory clarity would be welcome, we must be careful as to over-regulating the various cannabinoids (or compounds found in cannabis). It is likely that the FDA receives an influx of new drug applications following cannabis rescheduling, as FDA approval of any specific cannabinoids as drugs may be quite valuable. However, since FDA-approved medications cannot typically be legally added to conventional foods or dietary supplements, FDA approval of certain cannabinoids would create a complicated regulatory environment and spur subsequent consumer confusion (similar to the FDA’s approval of CBD in the form of Epidiolex). >Timeline >As for the timing of the rescheduling process, it will not happen overnight. Following approval by the White House, the DEA will likely initiate a public comment period. While this comment period itself will likely last from 30 to 90 days, the overall rescheduling process may take much longer. A previous drug rescheduling via rulemaking, for Hydrocodone Combination Products, took years to fully reschedule (though the timeline from HHS’ recommendation to the new rule taking effect was within one year). Following the quick turnaround by HHS to recommend cannabis rescheduling, it is possible that the DEA publishes its final rule as early as 2024.

phatbob198

>While Schedule III drugs may be legally prescribed and sold under federal law, the various restrictions (such as requiring FDA approval of any such Schedule III drug and DEA registration of a distributor) mean that your average dispensary, even medical dispensaries, will still be federally non-compliant. For these same reasons, the reclassification to Schedule III does not mean that marijuana grown pursuant to state programs can be sold in interstate commerce. Marijuana products, even under Schedule III, are only federally legal if they are federally approved and there are only three FDA-approved cannabis-based drugs developed to date (Marinol, Epdiolex, and Syndros). >The federal illegality of cannabis has thus prevented trademark registration in connection with most cannabis products. Unfortunately, cannabis rescheduling will not remedy this issue. Even in Schedule III, cannabis products would have to be federally lawful, with lawful use of a Schedule III drug requiring FDA approval. >Entitlement to Federal Bankruptcy Protection >Currently, plant-touching cannabis companies are not entitled to federal bankruptcy protection. That is because the U.S. Bankruptcy Code requires that bankruptcy plans are “proposed in good-faith and not by any means forbidden by law.” Since even state-regulated cannabis companies violate the federal Controlled Substances Act (CSA), they are disqualified. Unfortunately, rescheduling to Schedule III of the CSA alone will not likely solve that barrier to bankruptcy. >While some have argued otherwise, the fact is that to manufacture, distribute, or dispense a Schedule III Controlled Substance, businesses must be registered with the Drug Enforcement Administration (“DEA”). Any business or person not registered with the DEA is not authorized to manufacture, distribute, or dispense it. Meaning that violations would likely constitute an unlawful act under the CSA. Consequently, an attempt by the non-complying business to commence a voluntary petition seeking federal bankruptcy protection will likely result in a motion to dismiss the case by the U.S. Trustee’s Office. >However, in light of a recent trend among bankruptcy court’s in allowing ‘one-step-removed’ distribution of cannabis-related assets, federal rescheduling may very well result in a more liberalized approach to administering bankruptcy cases so that bankruptcy judges will be more willing to look past the issue of marijuana’s federal illegality. >There are several aspects of the existing cannabis industry which would not be immediately changed by rescheduling cannabis to Schedule III. Ongoing banking issues including the lack of access to standard commercial bank loans and lines of credit would likely persist; difficulties in processing cannabis transactions due to the reality that major credit card companies like Visa, Mastercard and others will likely still not service marijuana businesses; general federal illegality; and the criminalization of cannabis (and continued incarceration of certain offenders) in prohibitive states would remain following rescheduling.

Many_Easy

Markets don’t like uncertainty. Schedule III is now a certainty. Markets are also forward looking and fundamental analyses include present value of discounted future cash flows. Current uncertainties are Germany Pillar II, ability for LPs to export to U.S. OR U.S. importing from Canada, Florida vote, Farm Bill revisions, SAFE(R), improved operating results, uplistings, improvements to existing management teams, M&A, institutional investors, Canadian excise taxes, and surprises. All one has to do is review the list and to be patient. S3 was a huge step forward.

Bossie81

The Company has generated material operating losses since inception. The Company has had recurring net losses since inception which has resulted in an accumulated deficit of $82,450,781 and $79,556,028 as of December 31, 2023 and 2022, respectively, including net losses of $2,894,753 and $2,470,161 for the years ended December 31, 2023 and 2022, respectively. Historically, the Company has relied upon investor funds to maintain its operations and develop its business. The Company needs to raise additional capital from investors for working capital as well as business expansion, and there is no assurance that additional investor funds will be available on terms acceptable to the Company, or at all. If the Company is unable to unable to obtain additional financing to meet its working capital requirements, the Company likely would cease operations.   The Company requires funding of at least $5 million per year to maintain current operating activities. Over the next 24 months, the Company believes it will cost approximately $9 million to: (1) fund the FDA approval process to conduct human clinical trials; (2) conduct Phase I, pilot, and clinical trials; (3) activate several regional clinics to administer IsoPet^(®) across the county; (4) create an independent production center within the current production site to create a template for future international manufacturing; and (5) initiate regulatory approval processes outside of the United States.   The principal variables in the timing and amount of spending for the brachytherapy products in the next 12 to 24 months will be the FDA’s classification of the Company’s brachytherapy products as Class II or Class III devices (or otherwise) and any requirements for additional studies, which may possibly include clinical studies. Thereafter, the principal variables in the amount of the Company’s spending and its financing requirements would be the timing of any approvals and the nature of the Company’s arrangements with third parties for manufacturing, sales, distribution and licensing of those products and the products’ success in the U.S. and elsewhere. The Company intends to fund its activities through strategic transactions such as licensing and partnership agreements or additional capital raises.  

Keith_13

That's how about machines work in a few jurisdictions that only allow class II gaming. The slot machines are designed to mimic a pull tab, which is allowed under class II. Pretty much everywhere that has casinos allows class III gaming, which has real slot machines (every spin is random and independent) If this is about AC casinos, they are class III so what you are saying is not correct.

phatbob198

Once again, that is false. The DOJ Director of Public Affairs confirmed it. She is not anonymous. >Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III," **Justice Department director of public affairs Xochitl Hinojosa said in a statement**. The DEA is a component of the Department of Justice. "Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” https://abcnews.go.com/US/wireStory/us-drug-control-agency-move-reclassify-marijuana-historic-109794268

talktothepope

Well, hopefully it expands on it a bit considering how long it's taken Garland to get it out there. Also a lot has changed in 10 years. I'll allow Garland the excuse of waiting til Schedule III, but it's time to get moving bro

DEASqueezeAllComing

Well I guess the timing of the reddit user saying he will switch from investing to smoking it (he said it in the morning of schedule III) is not so bad after all. He still has a second chance to do both

RandomGenerator_1

Issuance of import permit. (a) The Administrator may authorize importation of any controlled substance listed in Schedule I or II or any narcotic drug listed in Schedule III, IV, or V if he finds: (1)Click to open paragraph tools That the substance is crude opium, poppy straw, concentrate of poppy straw, or coca leaves, in such quantity as the Administrator finds necessary to provide for medical, scientific, or other legitimate purposes; (2) That the substance is necessary to provide for medical and scientific needs or other legitimate needs of the United States during an emergency where domestic supplies of such substance or drug are found to be inadequate, or in any case in which the Administrator finds that competition among domestic manufacturers of the controlled substance is inadequate and will not be rendered adequate by the registration of additional manufacturers under section 303 of the Controlled Substances Act (21 U.S.C. 823); or (3) That the domestic supply of any controlled substance is inadequate for scientific studies, and that the importation of that substance for scientific purposes is only for delivery to officials of the United Nations, of the United States, or of any State, or to any person registered or exempted from registration under sections 1007 and 1008 of the Act (21 U.S.C. 957 and 958). https://www.ecfr.gov/current/title-21/chapter-II/part-1312/subject-group-ECFRc11ae182f37bc43 Import/Export Permit Applications and Declarations https://www.deadiversion.usdoj.gov/imp_exp/imp-exp.html

262Chief

"Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law." This is a huge problemo for uplisting. Higher exchanges need the "safe harbour" of listed companies being legally compliant in all jurisdictions in which they operate. Unless this industry move beyond the 52 State stovepipe, legal and regulatory risks, the sector aint going anywhere big business wise and will remain a novelty. Ask Irwin.... Aphria owned and operated US asset and left the US because of regulatory/legal risk.

PanicBuybeforeDump

Legal Consequences If Marijuana Moved to Schedule III Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law. With respect to medical marijuana, a key difference between placement in Schedule I and Schedule III is that substances in Schedule III have an accepted medical use and may lawfully be dispensed by prescription, while substances in Schedule I cannot. However, prescription drugs must be approved by the Food and Drug Administration (FDA). Although FDA has approved some drugs derived from or related to cannabis, marijuana itself is not an FDA-approved drug. Moreover, if one or more marijuana products obtained FDA approval, manufacturers and distributors would need to register with DEA and comply with regulatory requirements that apply to Schedule III substances in order to handle those products. Users of medical marijuana would need to obtain valid prescriptions for the substance from medical providers, subject to federal legal requirements that differ from existing state regulatory requirements for medical marijuana. Rescheduling marijuana would not affect the medical marijuana appropriations rider. Thus, so long as the current rider remains in effect, participants in the state-legal medical marijuana industry who comply with state law would be shielded from federal prosecution. If the rider were to lapse or be repealed, these persons would again be subject to prosecution at the discretion of DOJ. With respect to the manufacture, distribution, and possession of recreational marijuana, if marijuana were moved to Schedule III, such activities would remain illegal under federal law and potentially subject to federal prosecution regardless of their status under state law. [Legal Consequences of Rescheduling Marijuana (congress.gov)](https://crsreports.congress.gov/product/pdf/LSB/LSB11105)

PanicBuybeforeDump

Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law. With respect to medical marijuana, a key difference between placement in Schedule I and Schedule III is that substances in Schedule III have an accepted medical use and may lawfully be dispensed by prescription, while substances in Schedule I cannot. However, prescription drugs must be approved by the Food and Drug Administration (FDA). Although FDA has approved some drugs derived from or related to cannabis, marijuana itself is not an FDA-approved drug

PanicBuybeforeDump

**Legal Consequences If Marijuana Moved to Schedule III** Moving marijuana from Schedule I to Schedule III, without other legal changes, would not bring the state-legal medical or recreational marijuana industry into compliance with federal controlled substances law. With respect to medical marijuana, a key difference between placement in Schedule I and Schedule III is that substances in Schedule III have an accepted medical use and may lawfully be dispensed by prescription, while substances in Schedule I cannot. However, prescription drugs must be approved by the Food and Drug Administration (FDA). Although FDA has approved some drugs derived from or related to cannabis, marijuana itself is not an FDA-approved drug. Moreover, if one or more marijuana products obtained FDA approval, manufacturers and distributors would need to register with DEA and comply with regulatory requirements that apply to Schedule III substances in order to handle those products. Users of medical marijuana would need to obtain valid prescriptions for the substance from medical providers, subject to federal legal requirements that differ from existing state regulatory requirements for medical marijuana. Rescheduling marijuana would not affect the medical marijuana appropriations rider. Thus, so long as the current rider remains in effect, participants in the state-legal medical marijuana industry who comply with state law would be shielded from federal prosecution. If the rider were to lapse or be repealed, these persons would again be subject to prosecution at the discretion of DOJ. With respect to the manufacture, distribution, and possession of recreational marijuana, if marijuana were moved to Schedule III, such activities would remain illegal under federal law and potentially subject to federal prosecution regardless of their status under state law. Don't let Irwin Simon lie to you. [Legal Consequences of Rescheduling Marijuana (congress.gov)](https://crsreports.congress.gov/product/pdf/LSB/LSB11105)

ArnoldRothsteinsAlt

Well it wasn’t legalized and schedule III is still controlled. So the only thing that changes is the prison becomes a jail. It’s still illegal lol.

sharmoooli

After Phase II, Phase III takes a long time. This is the stage where there's less exclusion criteria and they have to show the results categorically beat any currently on the market treatments.

A-Wise-Cobbler

MedMen is bankrupt. Schedule III won’t be official for a few months.

phatbob198

Once again, this is false. The DOJ Director of Public Affairs confirmed it himself. He is not anonymous. >"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” **Justice Department Director of Public Affairs Xochitl Hinojosa said** in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act."

Gambelero

Very clever in his choice of words. “This will allow us to export medical cannabis.” Sure Canada will now let them export to the U.S., but no state allows imports. You can’t even ship from Georgia to Florida or California to Oregon. Schedule III might “allow” interstate commerce if states reach reciprocity agreements or possibly form commonwealth-like arrangements. Every state currently has its own particular regulatory framework and the MSOs work state by state within that framework. So, you have to carefully parse expressions like “allowed to export” or “interstate commerce permitted.”

-PsillyFunGuy-

It’s been posted ad nauseous in this sub but in case you can’t use google here is the quote from DOJ spokesperson Xochitl Hinojosa, “Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III.” It’s categorically not a rumor.

halfbeerhalfhuman

>"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” Is this the quote I see you keep posting? Im pretty sure it says clearly that nothing official has been posted yet. >“Once published by the Federal Register, Idk why you have to be so hostile though. Cant we all get a long. Just trying to rationalize price movement because if it was offical this wouldnt make sense. Thats all. Have a wonderful day <3

mealucra

WHY the fuck would he state this. We have a named source from the DOJ:  >“Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” [sauce](https://www.marijuanamoment.net/dea-agrees-to-reschedule-marijuana-under-federal-law-in-historic-move-following-biden-directed-health-agencys-recommendation/) Funny thing is, I was about to invest in GTI but right then the entire board quit. That usually doesn't happen unless there's something wrong with management.  Agreed that his twitter should be taken away. 🤦‍♂️

Fuego1050

Echelon : (on non official announcement) This leads us to believe that the DEA has reached a Schedule III decision. After the news, the AdvisorShares Pure US Cannabis ETF (MSOS-ARCA, NR) closed up 24.8% on Tuesday, though it has given back more than half of those gains with a decline of 15.0% on Wednesday. We view this as a buying opportunity for long-term investors, as the rescheduling progress has been substantially derisked with this week’s reports and confirmation by the DOJ Director of Public Affairs.

DEASqueezeAllComing

There's always going to be a bunch of bullies or trolls that like to stir BS. Joe Biden and Kamala Harris are serious about schedule III final ruling is all you need to know

skyplt29

From a 1 May Motley Fool write up.  I am not a big fan of MF, but do share this insight: If you ask me, though, the main reason marijuana stocks are selling off today is because marijuana investors made a lot of money yesterday, and they're cashing in their chips and taking profits. That's short-term thinking, however. Dropping marijuana two rungs to a Schedule III controlled substance is really good news for the industry and will accelerate the movement among states to legalize the drug both for medical purposes (as 38 have done) as well as for recreational purposes (as 24 have done). It will also provide some tax benefits for marijuana companies, permitting the deduction of certain operating expenses that could not be deducted when marijuana was a Schedule I drug. This will have a direct benefit for cannabis companies' bottom line, boosting profits and making marijuana stocks look cheaper as a result.

heizenbergbb

Remember that one night after hours when we thought world war III was starting, everyone was dumping the market, and Robinhood shut down their 24/7 trading during exactly the type of scenario you'd think it was designed for? Everyone moved on from that one pretty quickly.

creedthoughtsblog

“Today, [Attorney General Merrick Garland] circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Xochitl Hinojosa, the DOJ’s director of public affairs, said in a statement. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” god speed

A-Wise-Cobbler

If true this would validate my thought process. Other Schedule III drug manufacturers are on major stock exchanges. Why not marijuana producers if it gets rescheduled. Only stumbling block is retail is still illegal, which other Schedule III manufacturers obviously don’t do. Though since marijuana companies only operate in rec markets where it is state legal to do so. So … 🙏 … I hope 🤞

oldschoolczar

From u/Throwing_Horns Safe Harbor Financial CEO Sundie Seefried: The profound impact of rescheduling cannabis from Schedule I to Schedule III signifies a crucial shift in the perception of cannabis, recognizing its medical potential and solidifying its legitimacy in the financial realm. From a banking and lending perspective, we believe that the reclassification of cannabis will broaden lending opportunities for cannabis businesses, leading to access to lower interest rates, increased access to capital and improved financial stability across the industry. This newfound access to traditional financing channels has the potential to stimulate growth, innovation and compliance efforts within the industry, ultimately fostering economic development and job creation.

IceCoastRep

I think the news isn't as good as what people expected. It would now be a Schedule III drug....which includes ketamine, anabolic steroids, etc....which are still controlled substances. So it's not legal for recreational use at a federal level still. Everyone got excited on the news thinking it was going to be legal.

Cfrant190

How is no one mentioning that the title is wrong? Its not being delisted… its being reclassified from schedule I to III. That does not equal legal and also doesnt equal delisted

262Chief

Resched Risk..... Even if moved to Schedule III, the cultivation, manufacture, distribution, and sale of cannabis by state-regulated businesses that do not produce or sell FDA regulated products remains illegal under federal law. Unless and until the United States Congress amends the CSA with respect to cannabis, there is a risk that federal authorities may enforce current U.S. federal law. Currently, in the absence of uniform federal guidance, enforcement priorities are determined by respective United States Attorneys. If cannabis is re-categorized as a Schedule II or lower controlled substance, the resulting re-classification would result in the need for approval by United States Food and Drug Administration, or FDA, if medical claims are made about any medical cannabis products. As a result of such a re-classification, the manufacture, importation, exportation, domestic distribution, storage, sale and use of such products could become subject to a significant degree of regulation by the United States Drug Enforcement Administration, or DEA. In that case, companies may be required to be registered to perform these activities and have the security, control, recordkeeping, reporting and inventory mechanisms required by the DEA to prevent drug loss and diversion. Obtaining the necessary registrations may result in delay of the manufacturing or distribution of cannabis products. The DEA conducts periodic inspections of registered establishments that handle controlled substances. Failure to maintain compliance could have a material adverse effect on business, financial condition and results of operations. The DEA may seek civil penalties, refuse to renew necessary registrations, or initiate proceedings to restrict, suspend or revoke those registrations. In certain circumstances, violations could lead to criminal proceedings. Should the United States federal government legalize cannabis, it is possible that the FDA would seek to regulate it under the Food, Drug and Cosmetics Act of 1938. Additionally, the FDA may issue rules and regulations, including good manufacturing practices related to the growth, cultivation, harvesting and processing of medical cannabis. Clinical trials may be needed to verify efficacy and safety of any medical cannabis products.  It is also possible that the FDA would require that facilities where medical-use cannabis is grown register with the agency and comply with certain federally prescribed regulations. In the event that some or all of these regulations are imposed, the impact on the cannabis industry is uncertain and could include the imposition of new costs, requirements, and prohibitions. Inability to comply with the regulations or registration as prescribed by the FDA may have an adverse effect on our business, operating results, and financial condition.

DEASqueezeAllComing

24 hours ago, I was talking about a t-shirt I want to design to celebrate schedule III. Now I don't even want to have the reddit username I have , what a turm of events hahaha. Eventually we will rise from the ashes and defeat all the manipulation

Throwing_Horns

>**Safe Harbor Financial CEO Sundie Seefried:** *The profound impact of rescheduling cannabis from Schedule I to Schedule III signifies a crucial shift in the perception of cannabis, recognizing its medical potential and solidifying its legitimacy in the financial realm.* >*From a banking and lending perspective, we believe that the reclassification of cannabis will broaden lending opportunities for cannabis businesses, leading to access to lower interest rates, increased access to capital and improved financial stability across the industry. This newfound access to traditional financing channels has the potential to stimulate growth, innovation and compliance efforts within the industry, ultimately fostering economic development and job creation.*

CoolFirefighter930

This is correct, and legalization still has a long way to go . Is the schedule III in writing and approved yet?

MostlyH2O

Schedule III is not remotely close to legalization.

Jumpy_Elevator_6603

Think I'll homestead on the moon and sell all that sweet sweet helium III 

MrK81

What I'm reading is that Garland has, "circulated a proposal to reclassify marijuana from Schedule I to Schedule III" and that "once published by the Federal Register, will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act". Thoughts on action once it is actually published to the Federal Register?

theduderino38

lol yes ridiculously masochistic investments haha The way I see it- the start of the game and 1st inning is starting when Fed Registry is updated and sched III is on a Fed website. This is when the real game starts

sendnudezpls

Whoa down 5%?! Sounds like it's time for me to panic sell my GTI holdings that I've owned since 2018 - right before the impact of schedule III will drive enormous fundamental improvements, M&A, investment, uplisting, etc. ... lul no.

Business_Knee6165

Yes an official did state this: “Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” https://www.marijuanamoment.net/dea-agrees-to-reschedule-marijuana-under-federal-law-in-historic-move-following-biden-directed-health-agencys-recommendation/

phatbob198

>"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” **Justice Department Director of Public Affairs Xochitl Hinojosa said** in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” https://www.marijuanamoment.net/dea-agrees-to-reschedule-marijuana-under-federal-law-in-historic-move-following-biden-directed-health-agencys-recommendation/

phatbob198

>"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” **Justice Department Director of Public Affairs Xochitl Hinojosa said** in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act."

PMMeForAbortionPills

But banks finance Schedule III drug sales all the time. I don't get it

An-Okay-Alternative

The federal government has stood by while state level marijuana programs violated federal law for decades. That Biden would move it to schedule III is exactly the incrementalism he’s known for, giving him a headline win in an election year without drastically changing anything. That he would take aim at recreational weed in mostly Democratic states doesn’t make any sense.

TilrayOnCocaine

"Critics point out that as a Schedule III drug, marijuana would remain regulated by the DEA. That means the roughly 15,000 cannabis dispensaries in the U.S. would have to register with the DEA like regular pharmacies and fulfill strict reporting requirements, something that they are loath to do and that the DEA is ill equipped to handle" https://thehill.com/homenews/nexstar_media_wire/4633519-marijuana-could-be-rescheduled-would-that-make-it-legal-nationwide/ They will have to buy Cannabis from Tilray opppsiieee......

Born_Bet2239

It will be for a long time. The government is about to reclassify marijuana to a schedule III drug. This changes a ton of things for the better. It’s only up from here.

ColdWarVet90

I think I'm unclear on what that actually means. Tylenol and many others are OTC. But anabolics are Sched III and still illegal. Does this change mean the Feds plan to remove laws for Fed prosecution? Which then means it's really the states deciding legality.

DEASqueezeAllComing

I would like to thank Biden for giving us a second chance to add on the dip and making our lives great again. I'm thinking of making a custom t-shirt that says DEA Schedule III where each "I" is a big fat candle and on the back of the shirt a cannabis leaf with all the cannabis tickers

phatbob198

I saw this further down, but the flood of comments can drown stuff out. DOJ **confirmed** the AP story: >"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.” https://www.marijuanamoment.net/dea-agrees-to-reschedule-marijuana-under-federal-law-in-historic-move-following-biden-directed-health-agencys-recommendation/

phatbob198

The DOJ apparently confirmed: >"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.”

phatbob198

Yes apparently, DOJ: >"Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” Justice Department Director of Public Affairs Xochitl Hinojosa said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.”

john2557

I was talking to someone who I had previously tried to get to invest a little into cannabis stocks, mainly because I thought that schedule III was very likely, given all my research, the "tells" in the market, etc. He said that he didn’t understand how any company in this sector had / has a sustainable advantage. If schedule III happens, don’t margins get squeezed and with it becoming a commodity, due to the increased competition due to it being a more profitable business. Curious how you guys would respond to him?

Born_Bet2239

But your $TLRY and other weed stocks while they are cheap. The government switching weed to a schedule III drug is a huge deal. It impact their taxes as well, which will allow for more growth. Get em’ while they are cheap boys.

VisNihil

> federal legalization of medical marijuana under Schedule III It'll still be a controlled substance, requiring a DEA-number based prescription. This is still a long way off from full legalization.

taikotaki

Weed stocks are green cause the DEA is expected to reclassify marijewana to schedule III

noobstockinvestor

JUST IN: Justice Department **confirms** The attorney general has "circulated a proposal to reclassify marijuana from Schedule I to Schedule III," DOJ spokesperson says.

john2557

“Today, the Attorney General circulated a proposal to reclassify marijuana from Schedule I to Schedule III,” **Justice Department Director of Public Affairs Xochitl Hinojosa** said in a statement to Marijuana Moment on Tuesday evening. “Once published by the Federal Register, it will initiate a formal rulemaking process as prescribed by Congress in the Controlled Substances Act.”

greendoor_805

Today, we heard the welcome news that the DEA is agreeing with the HHS recommendation to move cannabis from Schedule I to Schedule III.  Boris Jordan, Executive Chairman of Curaleaf, joins at the top of the show to share his thoughts on the next steps in the process, the timing of a final ruling, potential risks along the way,  implications for institutional interest, and the specific impact of 280E on Curaleaf's business.  Hirsh Jain, founder of Ananda Strategy, joins for the second half and helps us better understand the similarities between cannabis's path to legalization and what happened with gay marriage. He also gives his perspective on the time frame for the DEA final ruling, advances in medical research, and how Schedule III may impact state election outcomes. We close by asking Hirsh his biggest concerns about this process and potential stumbling blocks.  

john2557

Oh, you silly person. Weed stocks don't care about J Pow, now that they got schedule III.

Bonzoso

No that will be in the SAFE banking bill if that ever fking passes dam GOP. It is closer then ever after finally clearing senate committee for first time since they've been introducing it for like 5 years lol. There's more hop with sched III allowing gop to vote for it now that weed doesn't = heroin

topstocksorg

Massive changes in cannabis laws with the federal legalization of medical marijuana under Schedule III—this is the biggest policy shift in 50 years. Expect major market moves as $1 billion in shorts get squeezed in the OTC market and favorites like $GTBIF and $CURLF may jump to major exchanges like NASDAQ/NYSE. With the new tax benefits, companies are looking at bigger profits. This could trigger the largest cannabis bull run we've ever seen. Dive into the details and get ready for some hefty gains!

TripleSmokedBacon

In my line of work, I have direct communications with certain people in the DEA with certain registrants. I was told, directly, in 2023 that they already made the internal decision to "likely agree to Schedule III" but it was purely a political decision. I actually expected this last December. The path forward, from what I understand, is that the "DEA does not reward crime." MSO's and similar will not be put out of business. But, unless they can obtain full DEA registration and then adhere to the set of regs the FDA has for quality and production standards, then there are zero tax benefits and product(s) will not be allowed to cross state lines. We will see how lenient the DEA chooses to be on the background of ownership of some of these organizations.

topstocksorg

Schedule III isn’t just about legality; it’s a game changer for financials too. Companies can now tally a broader range of accounting costs as deductible tax expenses. Translation? Instant boost in earnings the moment Schedule III gets the green light at the White House. I’m betting we’ll see the effects as soon as the next earnings season kicks off on May 8th. Expect most companies to start reporting potential profits under the new Schedule III framework. Look for earnings that not only meet but smash expectations. Super bullish!

Heatstorm2112

Definitely not. For example, alcohol nor tobacco are controlled substances in the US. There were calls for cannabis to be de-scheduled so that it would be treated in the same way as alcohol and tobacco. There are significantly different legal and financial differences between the sales of controlled substances (schedule III drug) vs. Non controlled substances. Just wondering if anyone had any opinions on how this affects US sales/operators in the future

HarryAreolas

Yes, schedule III.

Xalenn

Looks like they're planning to move it from Schedule I (illegal, no recognized medical use) to Schedule III (legal, risk of abuse, recognized medical use) ... So it would require a prescription. Not legal for recreational use. I'm not sure how much impact this move would have on businesses that are selling for recreational use in certain states

GP1294

Schedule III - could be federally legalized at that level, at least medically. Alot of prescription drugs are schedule II

mealucra

#🇺🇸 [CANNABIS](https://www.marijuanamoment.net/dea-agrees-to-reschedule-marijuana-under-federal-law-in-historic-move-following-biden-directed-health-agencys-recommendation/) 🔥🌲🗽 >The Drug Enforcement Administration (DEA) has made a historic decision—agreeing with the top federal health agency and proposing to move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). 💰💰💰

tantedbutthole

As of this second, yes. But once it’s rescheduled, like the article says, it will be able to cross state lines. It is no longer a schedule I drug with no known use. It’ll be Schedule III, which allows for it to be used, just has to be prescribed. But it will be able to cross state lines

talktothepope

Actually Schedule III would allow companies to deduct expenses that they can't deduct now thanks to 280e. It should provide an instant boost to the bottom line of MSOs (once it's actually done that is, probably still some BS to wade through, lawsuits etc before that happens) https://www.mpp.org/policy/federal/what-is-280e/

itsMalarky

Schedule III opens LPs with medical operations up to further investment, no?

tr1xus

It was always going to be something to negotiate down from. Like it has been for years. Schedule III just got rid of 280E so we don't need it anymore. It would help clarify a few things but the DEA just put the nail in.

NRG1975

For those interested: [BREAKING: DEA Will Reschedule Cannabis The federal agency that has long enforced prohibition has aligned with the recommendation from the FDA to reclassify cannabis as a Schedule III substance under the Controlled Substances Act, according to The Associated Press sources.](https://www.cannabisbusinesstimes.com/news/dea-reschedules-cannabis-schedule-3/#:~:text=The%20Drug%20Enforcement%20Administration%20\(DEA,according%20to%20The%20Associated%20Press.)

jpegdonkrider

It’s just that re-scheduling the drug to Schedule III doesn’t actually do anything for these businesses. It’s now the same schedule as Ketamine. It’s not legal. This doesn’t make it medically legal anywhere either (there’s only 10 states where it’s not medically legal anyway). I wish they would’ve decriminalized/legalized. That would’ve been massive. This is kind of a nothingburger in my opinion — hate to say it

Dontlookimnaked

“the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids” I don’t even smoke weed and this is WILD that marijuana has been on the same level as LSD and the big H

mealucra

>Once OMB signs off, the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids, following a recommendation from the federal Health and Human Services Department. After the public-comment period the agency would publish the final rule. Cannot fucking wait for DEA to officially confirm. 🙏

dvdmovie1

Discussion of "imminent" rescheduling to schedule III from schedule I

TheBeachWhale

> Once OMB signs off, the DEA will take public comment on the plan to move marijuana from its current classification as a Schedule I drug, alongside heroin and LSD. It moves pot to Schedule III, alongside ketamine and some anabolic steroids, following a recommendation from the federal Health and Human Services Department. After the public-comment period the agency would publish the final rule.

Friendly_Tomato_1236

Annovis Bio shares are trading lower after the company announced data from its Phase II/III Alzheimer study of buntanetap in mild to moderate Alzheimer's. Efficacy in the CGIC endpoint was not reached due to the limited number of patients and short trial duration. Pretty sure it will slowly climb back up, I got in at 6.24$.

5k_ultra_marathoner

Is schedule III priced in? What will MSOS get to if schedule III passes?

john2557

CBSTF trading at / near all-time low's with potential Schedule III months (or maybe even weeks) away. This market is...strange.

DEASqueezeAllComing

The story of this sector is DEA Don't Expect Anything SAFE nothing so far No Canada Excise Taxes No Schedule III

TheValgus

World War II happen before the nukes World War III will not look like World War II But I’m not surprised I don’t see someone eye to eye with someone who thinks it’s OK to use the word gay to describe something bad.

TheValgus

If you think you’re going to have profit in World War III, you are even stupider than I thought. Xi doesn’t care if this war kills every one of us: he wants Taiwan and he’s had a great life so far and he’s getting old. If you’re supporting China, you better live on another fucking planet otherwise you’re dumb. very very dumb

Gambelero

It’s not epidiolex 2.0. That was a drug with a known chemical composition that had been through three rounds of testing, including phase III clinical trials, and was approved by the FDA. New drugs approved by the FDA are covered under an entirely separate subsection of the law.

SPAC_Time

>RMG warrants down 80%+ this morning. ??? RMGC and RMGCW were [delisted by NASDAQ at close on April 22](https://www.businesswire.com/news/home/20240422615412/en/RMG-Acquisition-Corp.-III-Announces-Delisting-from-Nasdaq), and haven't been approved for listing on the OTC market yet, so not sure where you are seeing that quote. Maybe that was last sale price on April 22.

EternisedDragon

Based on their e-mail responses, they (among more) are with me on this issue: Prof. David Pearce, Prof. Dr. Kent A. Peacock, Prof. Dr. Greg Matloff, Dr. Anthony Milligan, Prof. Joanne Irene Gabrynowicz, Prof. Armel Kerrest, Prof. Preda Mihailescu, Dr. Jonathan H. Jiang, Prof. Dr. Philip Kotler, Michael Weinold, Dr. Julian Baggini, Bill Kitchen, Dr. Margaret Race, Paul Gilster, Prof. Dr. Tyler Cowen, Prof. Dr. Christopher E. Mason, Asher Soryl, B.A. Kevin Weller, Prof. Dr. Michael Schetsche, Prof. Vishaan Chakrabarti, Prof. Paula Casal, Robert Miles, Brian Tomasik, Isaac Brown, Dr. Scott Keating, Prof. Dr. Jacob Livingston Slosser, Jaroslav Jirík, David Lillis, Prof. Dr. David Christian, Mark J. Maharaj, Prof. Dr. Bill Schneider, Prof. Dr. Michael Reiss, Prof. Dr. Jim Olds, Jack Hancock, Erika Nesvold, Prof. Dr. Betül Kaçar, Prof. David Christian, Tim Ventura, Dr. Egbert Edelbroek, William Green, Marcus Chown, Maria Koskela, Catalina Sparleanu, Richard Wegscheider, Jenny Rompas, Mario Livio, Lena Halounova, M.Sc. Mariska Bosschart, Prof. Dr. Holmes Rolston III, Prof. Dr. Mary-Jane Rubenstein, Prof. Jin Zhouying, Max Theissen, Fin Moorhouse, Prof. Terence Barker, Rizacan Ciloglu, Volker Ossenkopf-Okada, José Miguel Rodriguez Espinosa, Franco Giovannelli, Vojtech Rusin, Amaury de Kertanguy, Alexa Stathakis, Volker W. Thürey, John Penrose, Teresa Mendes, Dr. Marie Francoise A. Ada, MoonXcribe, Katie &, ABIBOO, David Brin, Eugene F. Milone, potholer54, Prof. Satish Chitneni, Prof. Dr. Roger Crisp, William McCrary, Prof. Ian Crawford, Prof. Dr. Dirk Schulze-Makuch, Janne Heilala, Angella Fernando

Altruistic-Sense-593

But but muh World War III oil shock inflation rate hikes 🐻

ApostleThirteen

Meth is also a prescription drug, schedule III.

Business_Cheetah_737

So schedule III or SAFE first?

SirSteyr

In many orgs, there can be 7 levels to technical specialist roles which keeps the career treadmill going. Example: (Type) Engineer: I, II, III, IV, Senior, Staff, and Principal. You can hit all these roles without having direct reports. Unfortunately, outside tech, the compensation boosts across these roles might literally only be $50k - $60k despite the years it takes to climb that ladders. Whereas going from Technical Lead, Engineering Manager, Senior Manager, and Department VP might have a spread $300k. ^^Again ^^for ^^a ^^non-tech, ^^manufacturing ^^environment. ^^Tech ^^can ^^have ^^much ^^higher ^^baselines.

mealucra

Happy 420 everyone 🎄 Let's HOPE  for a SAFER CLIMB via uplist after SCH. III ✌️

SPAC_Time

[RMG Acquisition Corp. III Announces Cancellation of Dissolution](https://www.businesswire.com/news/home/20240419261410/en/RMG-Acquisition-Corp.-III-Announces-Cancellation-of-Dissolution/)

tmgarlauskas

WW III won’t be in the Middle East. It will start in the Indo Pacific region. Have the “I told you so” buttons ready to go. 😑

SmilingCowDog

WW III started in February 2022